KalVista Pharmaceuticals Inc logo

KalVista Pharmaceuticals Inc

NAS:KALV (USA)  
$ 12.08 -0.01 (-0.08%) 10:08 PM EST
At Loss
P/B:
4.72
Market Cap:
$ 509.63M
Enterprise V:
$ 441.91M
Volume:
217.89K
Avg Vol (2M):
447.82K
Also Trade In:
Volume:
217.89K
At Loss
Avg Vol (2M):
447.82K

Business Description

Description
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 10.15
Equity-to-Asset 0.78
Debt-to-Equity 0.08
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 64.66
9-Day RSI 60.41
14-Day RSI 55.25
6-1 Month Momentum % 47.83
12-1 Month Momentum % 22.61

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.44
Quick Ratio 5.44
Cash Ratio 3.95

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24.2
Shareholder Yield % 0.15